Welcome to the Oncomine Blog
Evaluation of Rapid Next-Generation Sequencing for the Study of Acute Myeloid Leukemia
03/11/2022 |
Hemato-oncology
In a recent GenomeWeb webinar, Rapid next-generation sequencing for the study of acute myeloid leukemia (AML), Dr. Diana Morlote from The University...
-
Evaluation of Rapid Next-Generation Sequencing for the Study of Acute Myeloid Leukemia
In a recent GenomeWeb webinar, Rapid next-generation sequencing for the study of acute myeloid leuke... -
Collaborating Early to Advance Precision Medicine – A Look Inside Thermo Fisher’s CDx Program with Garret Hampton
Companion diagnostic (CDx) tests are powerful tools in precision medicine and help advance more wide... -
The Impact of Rapid Molecular Diagnosis on Precision Medicine in Acute Myeloid Leukemia
Advances in next-generation sequencing have improved our understanding of the complexity and molecul... -
2021 European Association for Haematopathology Virtual Meeting Highlights
2021 EAHP Symposium Overview As part of the 20th Meeting of the European Association for Haematopath... -
NGS Enables Precision Oncology in Community-Based Hospitals
Next-generation sequencing (NGS) technology has changed cancer treatment by enabling pathologists an... -
How Diagnostics can Revolutionize Patient Care: Insights from the Precision Medicine Leader Summit
Precision medicine is a holistic approach to healthcare that combines knowledge of an individuals’ g... -
University of Munich Evaluates the Oncomine Comprehensive Plus Assay for HRD Detection
Our OncomineWorld event in 2021 brought thousands of professionals together from around the world to... -
Case Study: High-Quality, Cost-Effective Genomic Testing and Genetic Profiling using NGS
In a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at th... -
Q&A: An Inside Look at Immune Repertoire Assay Development with Dr. Geoffrey Lowman
Dr. Geoffrey Lowman Senior Staff Scientist, Molecular Biology, Clinical Sequencing Division Thermo F...